Snowball logo
logo
APRE

Aprea Therapeutics, Inc

APRE โ€ข NASDAQ
$0.941+$0.061ย  (6.93%)

Frequently asked questions

What sector does Aprea Therapeutics, Inc (APRE) operate in?

Aprea Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Aprea Therapeutics, Inc (APRE) current stock price?

As of the latest data, Aprea Therapeutics, Inc stock price is $0.94, with a previous close of $0.88. Aprea Therapeutics, Inc gained $0.06 in the last trading session, representing a 6.93% increase.

What is Aprea Therapeutics, Inc (APRE) current market capitalization?

Aprea Therapeutics, Inc market cap is approximately 11.28 million.

What is Aprea Therapeutics, Inc (APRE) Earnings Per Share (EPS)?

The trailing EPS is -$1.93, and the forward EPS is -$0.66.

What is Aprea Therapeutics, Inc (APRE) EBITDA?

Aprea Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.64 million.

Does Aprea Therapeutics, Inc (APRE) pay dividends?

No. Aprea Therapeutics, Inc does not pay a dividend.

How did Aprea Therapeutics, Inc (APRE) perform in its most recent earnings report?

In the last report (December 31, 2025), Aprea Therapeutics, Inc posted an EPS surprise of 11.11% and a revenue surprise of -98.84%.

What is Aprea Therapeutics, Inc (APRE) beta (volatility) score?

Aprea Therapeutics, Inc has a beta of 1.574, suggesting it is more volatile than the market.